Clinical trial
A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLC
NCT03085069
Study timeline
Study start (actual)2017-05-03Date precision: day
Registry last updated2023-02-16
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Neoplasmsunresolved
Carcinoma, Non-Small-Cell Lungunresolved
Respiratory Tract Neoplasms Necunresolved
Lung Diseaseunresolved
Respiratory Tract Diseaseunresolved
Neoplasm, Bronchialunresolved
Carcinoma, Bronchogenicunresolved
Interventions
SHR-1210BIOLOGICAL
Sponsors & collaborators
Jiangsu HengRui Medicine Co., Ltd.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03085069 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.